Semin Thromb Hemost 2018; 44(04): 334-340
DOI: 10.1055/s-0037-1612625
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Prevalence and Risk Factors of Acute Pulmonary Embolism in Patients with Lung Cancer Surgery

Yu-ping Li
1   Department of General Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China
,
Lei Shen
1   Department of General Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China
,
Wei Huang
1   Department of General Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China
,
Xue-fei Hu
1   Department of General Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China
,
Dong Xie
1   Department of General Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China
,
Jian Yang
1   Department of General Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China
,
Xiao Song
1   Department of General Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China
,
Yan-feng Zhao
1   Department of General Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China
,
Chao-jie Zhou
1   Department of General Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China
,
Ge-ning Jiang
1   Department of General Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China
› Author Affiliations
Funding Statement This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Further Information

Publication History

Publication Date:
10 January 2018 (online)

Abstract

Acute pulmonary embolism (PE) is one of the serious complications with high mortality after thoracic surgery. The authors aimed to determine the prevalence of PE events and evaluate additional risk factors for PE in patients with lung cancer surgery. Patients underwent lung cancer resections during January 2012 to July 2015 and had 30-day postoperative follow-up were included. Those with incomplete or miscoded data were excluded. The number of postoperative PE events was recorded retrospectively. Analyses were used to evaluate risk factors of PE during the hospitalization. The authors reviewed 11,474 patients who underwent surgery for lung cancer. The overall 30-day incidence of PE after thoracic surgery at their institution was 0.53%. The 30-day PE incidence without chemical prophylaxis was 0.57% (55/9,726) and the mortality rate was 10%. Multivariate analyses revealed that age over 66 (odds ratio [OR]: 1.09, 95% confidence interval [CI]: 1.05–1.12, p < 0.001), more extensive surgery than lobectomy (OR: 2.34, 95% CI: 1.28–4.25, p = 0.006) and stage IV of lung cancer (OR: 4.22, 95% CI: 1.50–11.9, p = 0.007) were associated with an increased risk of PE. Using these additional risk factors, based on readily available clinical characteristics, can help to risk-stratify patients and warrant extended chemical prophylaxis for patients to reduce the incidence of acute PE.

 
  • References

  • 1 Christensen TD, Vad H, Pedersen S. , et al. Venous thromboembolism in patients undergoing operations for lung cancer: a systematic review. Ann Thorac Surg 2014; 97 (02) 394-400
  • 2 Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH. Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer 2007; 110 (10) 2339-2346
  • 3 Konstantinides SV, Torbicki A, Agnelli G. , et al; Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014; 35 (43) 3033-3069 , 3069a–3069k
  • 4 Paul S, Sedrakyan A, Chiu YL. , et al. Outcomes after lobectomy using thoracoscopy vs thoracotomy: a comparative effectiveness analysis utilizing the Nationwide Inpatient Sample database. Eur J Cardiothorac Surg 2013; 43 (04) 813-817
  • 5 Paul S, Altorki NK, Sheng S. , et al. Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS database. J Thorac Cardiovasc Surg 2010; 139 (02) 366-378
  • 6 Yang Y, Liang L, Zhai Z. , et al; Investigators for National Cooperative Project for Prevention and Treatment of PTE-DVT. Pulmonary embolism incidence and fatality trends in Chinese hospitals from 1997 to 2008: a multicenter registration study. PLoS One 2011; 6 (11) e26861
  • 7 Dentali F, Malato A, Ageno W. , et al. Incidence of venous thromboembolism in patients undergoing thoracotomy for lung cancer. J Thorac Cardiovasc Surg 2008; 135 (03) 705-706
  • 8 Gould MK, Garcia DA, Wren SM. , et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2, Suppl): e227S-e277S
  • 9 Nagahiro I, Andou A, Aoe M, Sano Y, Date H, Shimizu N. Intermittent pneumatic compression is effective in preventing symptomatic pulmonary embolism after thoracic surgery. Surg Today 2004; 34 (01) 6-10
  • 10 Daddi G, Milillo G, Lupattelli L. , et al; Pulmonary Embolism in Thoracic Surgery Study Group. Postoperative pulmonary embolism detected with multislice computed tomography in lung surgery for cancer. J Thorac Cardiovasc Surg 2006; 132 (01) 197-198
  • 11 Mason DP, Quader MA, Blackstone EH. , et al. Thromboembolism after pneumonectomy for malignancy: an independent marker of poor outcome. J Thorac Cardiovasc Surg 2006; 131 (03) 711-718
  • 12 Zhang PP, Sun JW, Wang XY, Liu XM, Li K. Preoperative plasma D-dimer levels predict survival in patients with operable non-small cell lung cancer independently of venous thromboembolism. Eur J Surg Oncol 2013; 39 (09) 951-956
  • 13 Hewes PD, Hachey KJ, Zhang XW. , et al. Evaluation of the Caprini model for venothromboembolism in esophagectomy patients. Ann Thorac Surg 2015; 100 (06) 2072-2078
  • 14 De Martino RR, Goodney PP, Spangler EL. , et al. Variation in thromboembolic complications among patients undergoing commonly performed cancer operations. J Vasc Surg 2012; 55 (04) 1035-1040.e4
  • 15 Xu X, Yang H, Qiao L. , et al. [Clinical characteristic and outcomes of lung cancer patients with venous thromboembolism]. Zhonghua Yi Xue Za Zhi 2014; 94 (26) 2045-2049
  • 16 Li R, Hermann G, Baldini E. , et al. Advanced nodal stage predicts venous thromboembolism in patients with locally advanced non-small cell lung cancer. Lung Cancer 2016; 96: 41-47
  • 17 Hachey KJ, Hewes PD, Porter LP. , et al. Caprini venous thromboembolism risk assessment permits selection for postdischarge prophylactic anticoagulation in patients with resectable lung cancer. J Thorac Cardiovasc Surg 2016; 151 (01) 37-44.e1
  • 18 Heit JA, Silverstein MD, Mohr DN. , et al. The epidemiology of venous thromboembolism in the community. Thromb Haemost 2001; 86 (01) 452-463
  • 19 Heit JA, O'Fallon WM, Petterson TM. , et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med 2002; 162 (11) 1245-1248
  • 20 Caprini JA. Thrombosis risk assessment as a guide to quality patient care. Dis Mon 2005; 51 (2-3): 70-78
  • 21 Caprini JA. Risk assessment as a guide to thrombosis prophylaxis. Curr Opin Pulm Med 2010; 16 (05) 448-452
  • 22 Novis SJ, Havelka GE, Ostrowski D. , et al. Prevention of thromboembolic events in surgical patients through the creation and implementation of a computerized risk assessment program. J Vasc Surg 2010; 51 (03) 648-654
  • 23 Shen L, Li Y, Hernandez-Arenas LA, Jiang G, Yang J. Successful treatment of a pulmonary embolism with low dose of tissue plasminogen activator after thoracic surgery. Am J Emerg Med 2016; 34 (11) 2259.e5-2259.e6